相关实验视频
Updated: Jul 26, 2025

Preclinical Model of Hind Limb Ischemia in Diabetic Rabbits
Published on: June 2, 2019
作为糖尿病血管并发症的新型治疗点Nox4
Dongxia Wang1, Jiaying Li2, Gang Luo3
1Department of Nutrition and Food Hygiene, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Hubei Key Laboratory of Food Nutrition and Safety, Ministry of Education Key Laboratory of Environment, Wuhan, 430030, China; Department of Nutrition and Food Hygiene, School of Public Health, Hebei Medical University, Hebei Key Laboratory of Environment and Human Health, Shijiazhuang, 050017, China.
来自Nox4的氧化应激会导致糖尿病的微血管并发症,如脏疾病. 用药物或饮食准Nox4可以预防和治疗这些严重的糖尿病问题.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 病理生理学 病理生理学
背景情况:
- 糖尿病血管并发症会影响微血管和宏血管系统.
- 氧化压力与糖尿病的微血管并发症有关,包括病,视网膜病,神经病和心肌病.
- NADPH氧化酶的Nox家族是活性氧物种 (ROS) 的关键来源,并调节糖尿病的氧化还原信号.
研究的目的:
- 审查Nox4在糖尿病微血管病变中的作用和调节.
- 为突出在糖尿病病中Nox4上调调的新进展.
- 探索新的机制,包括表观遗传学,通过Nox4调节糖尿病微血管病变.
主要方法:
- 关于Nox4.4的当前知识的文献综述.
- 对糖尿病病中Nox4上调调节的最新发现的分析.
- 检查Nox4.4的表观遗传和其他新型调节机制.
主要成果:
- 在糖尿病病中,NOx4上调会加剧各种细胞类型.
- 通过各种调节机制,Nox4在糖尿病微血管病变的发病过程中发挥着重要作用.
- 有证据将Nox4与糖尿病大血管病症联系起来.
结论:
- 诺克斯4是糖尿病微血管并发症的关键调解者.
- 向Nox4为糖尿病微血管病变提供了一个有前途的治疗策略.
- 对Nox4调节和治疗干预措施的进一步研究是有必要的.
更多相关视频
相关概念视频
Dipeptidyl Peptidase 4 Inhibitors
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Regulation of Angiogenesis and Blood Supply
Insulin: The Receptor and Signaling Pathways
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:

